ATLAS ARTERIA (ALX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALX - ATLAS ARTERIA

FNArena Sector : Infrastructure & Utilities
Year End: December
GICS Industry Group : Transportation
Debt/EBITDA: 26.84
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Atlas Arteria, formerly known as Macquarie Atlas Roads, is a global owner, operator and developer of toll roads. It was created and listed in 2010 following the restructuring of the Macquarie Infrastructure Group.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.81

20 Nov
2024

-0.020

OPEN

$4.89

-0.41%

HIGH

$4.91

1,579,476

LOW

$4.80

TARGET
$5.343 11.1% upside
OTHER COMPANIES IN THE SAME SECTOR
AGL . AIA . APA . CEN . DBI . DBI . GNE . GNP . MEZ . ORG . SRJ . TCL .
FNARENA'S MARKET CONSENSUS FORECASTS
ALX: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx 17.7 33.3 xxx
DPS (cps) xxx 40.0 40.0 xxx
EPS Growth xxx - 20.5% 88.2% xxx
DPS Growth xxx 0.0% 0.0% xxx
PE Ratio xxx N/A 14.3 xxx
Dividend Yield xxx N/A 8.4% xxx
Div Pay Ratio(%) xxx 226.4% 120.3% xxx

Dividend yield today if purchased 3 years ago: 6.02%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

8.40

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 24/09 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx17.7
DPS All xxxxxxxxxxxxxxx40.0
Sales/Revenue xxxxxxxxxxxxxxx134.0 M
Book Value Per Share xxxxxxxxxxxxxxx429.8
Net Operating Cash Flow xxxxxxxxxxxxxxx713.6 M
Net Profit Margin xxxxxxxxxxxxxxx191.27 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx4.03 %
Return on Invested Capital xxxxxxxxxxxxxxx3.21 %
Return on Assets xxxxxxxxxxxxxxx3.13 %
Return on Equity xxxxxxxxxxxxxxx4.03 %
Return on Total Capital xxxxxxxxxxxxxxx-0.06 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx132.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx102 M
Long Term Debt xxxxxxxxxxxxxxx1,619 M
Total Debt xxxxxxxxxxxxxxx1,721 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx305 M
Price To Book Value xxxxxxxxxxxxxxx1.34

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.8 M
Capex % of Sales xxxxxxxxxxxxxxx0.60 %
Cost of Goods Sold xxxxxxxxxxxxxxx118 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx22 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx5,547 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.4

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

1

xxxxxxxxxx xx xxxxxxxx xxxx xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

15/10/2024

3

Hold

$4.76

-1.04%

Morgans highlights the increasing geo-political risks of conducting business in France, with the proposed supplemental tax bill which has the potential to impact on Atlas Arteria's APRR, of which the operator has a 31% stake.

The tax has yet to be approved. The analyst estimates a circa -11c per share impact on distributable cash flow in FY25 to FY26 if the tax is approved. A similar impact would be expected on the forecast valuation.

Target eases to $4.76 from $4.97 which includes a premium for a potential takeover. Hold retained.

FORECAST
Morgans forecasts a full year FY24 dividend of 40.00 cents and EPS of 26.00 cents.
Morgans forecasts a full year FY25 dividend of 37.00 cents and EPS of 37.00 cents.

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

ALX STOCK CHART